Literature DB >> 2500251

Determinants of target gene specificity for steroid/thyroid hormone receptors.

K Umesono1, R M Evans.   

Abstract

The molecular specificity of the receptors for steroid and thyroid hormones is achieved by their selective interaction with DNA binding sites referred to as hormone response elements (HREs). HREs can differ in primary nucleotide sequence as well as in the spacing of their dyadic half-sites. The target gene specificity of the glucocorticoid receptor can be converted to that of the estrogen receptor by changing three amino acids clustered in the first zinc finger. Remarkably, a single Gly to Glu change in this region produces a receptor that recognizes both glucocorticoid and estrogen response elements. Further replacement of five amino acids in the stem of the second zinc finger transforms the specificity to that of the thyroid hormone receptor. These findings localize structural determinants required for discrimination of HRE sequence and half-site spacing, respectively, and suggest a simple pathway for the coevolution of receptor DNA binding domains and hormone-responsive gene networks.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500251     DOI: 10.1016/0092-8674(89)90051-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  196 in total

1.  Identification of the histamine H1 receptor gene as a differentially repressed target of the human TR2 orphan receptor.

Authors:  H J Lee; Y F Lee; C Chang
Journal:  Mol Cell Biochem       Date:  1999-04       Impact factor: 3.396

2.  Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains.

Authors:  E Schoenmakers; P Alen; G Verrijdt; B Peeters; G Verhoeven; W Rombauts; F Claessens
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

3.  The dual role of ultraspiracle, the Drosophila retinoid X receptor, in the ecdysone response.

Authors:  N Ghbeish; C C Tsai; M Schubiger; J Y Zhou; R M Evans; M McKeown
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

4.  The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene.

Authors:  R Sladek; J A Bader; V Giguère
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

5.  DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation.

Authors:  Annemie Haelens; Guy Verrijdt; Leen Callewaert; Valerie Christiaens; Kris Schauwaers; Ben Peeters; Wilfried Rombauts; Frank Claessens
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

6.  Differential modes of activation define orphan subclasses within the steroid/thyroid receptor superfamily.

Authors:  J P Lydon; R F Power; O M Conneely
Journal:  Gene Expr       Date:  1992

7.  Overlap of the p53-responsive element and cAMP-responsive element in the enhancer of human T-cell leukemia virus type I.

Authors:  N Aoyama; T Nagase; T Sawazaki; G Mizuguchi; H Nakagoshi; J I Fujisawa; M Yoshida; S Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

8.  The C'-terminal interaction domain of the thyroid hormone receptor confers the ability of the DNA site to dictate positive or negative transcriptional activity.

Authors:  J M Holloway; C K Glass; S Adler; C A Nelson; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

9.  A functional glucocorticoid-responsive unit composed of two overlapping inactive receptor-binding sites: evidence for formation of a receptor tetramer.

Authors:  M Garlatti; M Daheshia; E Slater; J Bouguet; J Hanoune; M Beato; R Barouki
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Structure of the heterodimeric ecdysone receptor DNA-binding complex.

Authors:  Srikripa Devarakonda; Joel M Harp; Youngchang Kim; Andrzej Ozyhar; Fraydoon Rastinejad
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.